Drug General Information
Drug ID
D0FK6T
Former ID
DNC004855
Drug Name
2-(4-Cyclopentyl-piperazin-1-yl)-quinoline
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527370]
Structure
Download
2D MOL

3D MOL

Formula
C18H23N3
Canonical SMILES
C1CCC(C1)N2CCN(CC2)C3=NC4=CC=CC=C4C=C3
InChI
1S/C18H23N3/c1-4-8-17-15(5-1)9-10-18(19-17)21-13-11-20(12-14-21)16-6-2-3-7-16/h1,4-5,8-10,16H,2-3,6-7,11-14H2
InChIKey
JGCMOVVEQUHZRT-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Histamine H3 receptor Target Info Inhibitor [527370]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Histamine receptors
G alpha (i) signalling events
WikiPathways Monoamine Transport
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 527370J Med Chem. 2005 Jan 13;48(1):306-11.2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.
Ref 527370J Med Chem. 2005 Jan 13;48(1):306-11.2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.